Acute Kidney Injury After Efavirenz/Tenofovir Disoproxil Fumarate/Emtricitabine (Atripla) Overdose

Thomas Havenith; David Burger; Maarten J Visschers; Jolanda Schippers; Astrid Oude Lashof

doi:10.1097/FTD.0000000000000386

Acute Kidney Injury After Efavirenz/Tenofovir Disoproxil Fumarate/Emtricitabine (Atripla) Overdose

Thomas Havenith^*, David Burger, Maarten J Visschers, Jolanda Schippers, Astrid Oude Lashof

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

We describe a patient with acute renal failure and irreversible kidney damage after an overdose with the fixed dose combination of efavirenz/tenofovir disoproxil fumarate/emtricitabine (Atripla). The acute kidney injury was most probably caused by tenofovir. Efavirenz and emtricitabine seemed relatively safe in overdose. The pharmacokinetics in overdose of all 3 drugs and the effect of hemodialysis on the tenofovir clearance were studied by measuring the plasma concentrations and by the use of clinical pharmacokinetic software.

Original language	English
Pages (from-to)	91-92
Number of pages	2
Journal	Therapeutic Drug Monitoring
Volume	39
Issue number	2
DOIs	https://doi.org/10.1097/FTD.0000000000000386
Publication status	Published - Apr 2017

Keywords

Acute Kidney Injury
Anti-HIV Agents
Benzoxazines
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Emtricitabine
HIV Infections
HIV-1
Humans
Male
Middle Aged
Tenofovir
Case Reports
Journal Article

Access to Document

10.1097/FTD.0000000000000386

Cite this

@article{470348e26dc041e1a2590f55c58ab86c,

title = "Acute Kidney Injury After Efavirenz/Tenofovir Disoproxil Fumarate/Emtricitabine (Atripla) Overdose",

abstract = "We describe a patient with acute renal failure and irreversible kidney damage after an overdose with the fixed dose combination of efavirenz/tenofovir disoproxil fumarate/emtricitabine (Atripla). The acute kidney injury was most probably caused by tenofovir. Efavirenz and emtricitabine seemed relatively safe in overdose. The pharmacokinetics in overdose of all 3 drugs and the effect of hemodialysis on the tenofovir clearance were studied by measuring the plasma concentrations and by the use of clinical pharmacokinetic software.",

keywords = "Acute Kidney Injury, Anti-HIV Agents, Benzoxazines, Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination, Emtricitabine, HIV Infections, HIV-1, Humans, Male, Middle Aged, Tenofovir, Case Reports, Journal Article",

author = "Thomas Havenith and David Burger and Visschers, {Maarten J} and Jolanda Schippers and {Oude Lashof}, Astrid",

year = "2017",

month = apr,

doi = "10.1097/FTD.0000000000000386",

language = "English",

volume = "39",

pages = "91--92",

journal = "Therapeutic Drug Monitoring",

issn = "0163-4356",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

number = "2",

}

TY - JOUR

T1 - Acute Kidney Injury After Efavirenz/Tenofovir Disoproxil Fumarate/Emtricitabine (Atripla) Overdose

AU - Havenith, Thomas

AU - Burger, David

AU - Visschers, Maarten J

AU - Schippers, Jolanda

AU - Oude Lashof, Astrid

PY - 2017/4

Y1 - 2017/4

N2 - We describe a patient with acute renal failure and irreversible kidney damage after an overdose with the fixed dose combination of efavirenz/tenofovir disoproxil fumarate/emtricitabine (Atripla). The acute kidney injury was most probably caused by tenofovir. Efavirenz and emtricitabine seemed relatively safe in overdose. The pharmacokinetics in overdose of all 3 drugs and the effect of hemodialysis on the tenofovir clearance were studied by measuring the plasma concentrations and by the use of clinical pharmacokinetic software.

AB - We describe a patient with acute renal failure and irreversible kidney damage after an overdose with the fixed dose combination of efavirenz/tenofovir disoproxil fumarate/emtricitabine (Atripla). The acute kidney injury was most probably caused by tenofovir. Efavirenz and emtricitabine seemed relatively safe in overdose. The pharmacokinetics in overdose of all 3 drugs and the effect of hemodialysis on the tenofovir clearance were studied by measuring the plasma concentrations and by the use of clinical pharmacokinetic software.

KW - Acute Kidney Injury

KW - Anti-HIV Agents

KW - Benzoxazines

KW - Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination

KW - Emtricitabine

KW - HIV Infections

KW - HIV-1

KW - Humans

KW - Male

KW - Middle Aged

KW - Tenofovir

KW - Case Reports

KW - Journal Article

U2 - 10.1097/FTD.0000000000000386

DO - 10.1097/FTD.0000000000000386

M3 - Article

C2 - 28230617

SN - 0163-4356

VL - 39

SP - 91

EP - 92

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

IS - 2

ER -